Search results for “Congestive heart disease” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 374 patents, we discovered top 64 key players by total patent application. CV Therapeutics, Inc., Eli Lilly & Co., Orion Corp are dominant in this area. They take 41.71% of the total patent filing.
CV Therapeutics, Inc.
California, United States
Patent: 95
Eli Lilly & Co.
Indiana, United States
Patent: 38
Orion Corp
South Korea
Patent: 23
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 20
Gilead Palo Alto, Inc.
California, United States
Patent: 14
Acorn Cardiovascular, Inc.
Minnesota, United States
Patent: 11
G.D. Searle LLC
Illinois, United States
Patent: 10
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 10
Cedona Pharmaceuticals BV
Netherlands
Patent: 10
Sanofi Pharma
Belgium
Patent: 10
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 4 patents applied in the last 5 years. We discover 1 most active companies in this area.
Intra-Cellular Therapies, Inc.
New York, United States
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 9 patents, we discovered top 1 universities and scientific research institutions by total patent application.
University of British Columbia
British Columbia, Canada
Patent: 4
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: